New therapeutic cocktails show promise for long-lasting asthma relief

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma...

Gut Microbiome and Allergic Diseases: A Revolutionary Paradigm for Prevention and Treatment

The human gastrointestinal tract harbors a complex ecosystem of trillions of microorganisms that collectively constitute the gut microbiome,...

NIH clinical trial examines investigational therapy for dengue

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to...

Scientists develop promising new drug candidates against coronaviruses

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise...

Bach2 protein identified as key regulator in atopic dermatitis

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to social...

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature...

Children with peanut allergy achieve tolerance with gradual peanut butter ingestion

Eating gradually increasing doses of store-bought, home-measured peanut butter for about 18 months enabled 100% of children with...

Study explores how nanoplastics could affect child’s immune system during pregnancy

Allergies and asthma are widespread diseases that could arise during embryonal development in the womb. A team led...

Gut bacteria could one day serve as microscopic in-house pharmacists

Hundreds of different species of microbes live, laugh, and love in your gut. In the future, one of...

Long-acting HIV injections show success in patients with struggles to take daily pills

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the...

EBV exposure linked to life-threatening cancer risk in kidney transplant patients

More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr...

Social media and peer pressure fueling dangerous drug misuse

Social media trends and peer pressure can be a dangerous combination to your children and their friends, especially...

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is...

Probiotics improve emotional state in healthy adults, study finds

Daily mood reports reveal what traditional questionnaires miss — probiotics may lift negative emotions in healthy people, opening...

Study reveals an integrated care model for improving outcomes among people who inject drugs

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the...

Growth factor cocktail could reverse deadly effects of anthrax toxin

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But...

Researchers develop mouse model to study neutrophilic asthma

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative...

Discovery of special dendritic cells sheds light on food allergy prevention

The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or...

Daily peanut doses help adults overcome severe allergies

The first clinical trial to test whether adults allergic to peanuts can be desensitized has shown great success...

Single dose of antibody shields macaques from severe H5N1 influenza

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing...

Increased allergy symptoms tied to changing climate patterns

A review published in The Laryngoscope indicates that climate change's effects on pollen seasons and concentrations are contributing to increasing rates of allergic rhinitis, or hay fever.

When investigators assessed research published between 2000 and 2023, they identified 30 studies that reported on the current epidemiological state of allergic rhinitis, described factors related to climate change, and observed how global warming is affecting pollen seasons and allergy symptoms.

Sixteen studies reported longer pollen seasons and/or higher pollen concentrations related to climate change. As an example, total pollen emissions in the U.S. are projected to increase by 16–40% by the end of the century and pollen season length to increase by 19 days. Four studies reported an increase in allergic rhinitis–related health care usage, particularly among low-income residents. Two studies reported that health care professionals want more education on climate change. 

Physicians are uniquely positioned to witness the impact of allergic rhinitis on patient outcomes and can adapt their practice as climate change intensifies. As trusted voices in the community, they should leverage their frontline experience to advocate for meaningful change in addressing the climate crisis."

Alisha R. Pershad, BS, corresponding author, a third-year medical student, George Washington University School of Medicine and Health Sciences

Source:

Wiley

Journal reference:

Pershad, A. R., et al. (2025) How Climate Change Is Impacting Allergic Rhinitis: A Scoping Review. The Laryngoscope. doi.org/10.1002/lary.32124.


Source: http://www.news-medical.net/news/20250409/Increased-allergy-symptoms-tied-to-changing-climate-patterns.aspx

Inline Feedbacks
View all comments
guest